Work

Supplementary Materials and Methods from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Materials and Methods from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361840238
Cites: 3
Cited by:
Related to: 10